Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer

References

• Nossier AI, Eissa S, Ismail MF, et al. Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer. Biosens Bioelectron. 2014;54:7–14.
   PubMed Web of Science ®Google Scholar
• Zhou DH, Zhang G, Gan ZH. c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer. J Control Release. 2013;169:204–210.
   PubMed Web of Science ®Google Scholar
• Jeong KC, Kim KT, Seo HH, et al. Intravesical Instillation of c-MYC Inhibitor KSI-3716 suppresses orthotopic bladder tumor growth. J Urology. 2014;191:510–518.
   PubMed Web of Science ®Google Scholar
• Akiou O, Naoto O, Kenzo K, et al. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C. J Dermatol. 2009;36:419–422.
   PubMed Web of Science ®Google Scholar
• Catherine LV, Nathalie RL, Michael H, et al. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer. J Urology. 2004;171:1324–1329.
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun P, Li P, et al. A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer. Biomaterials. 2013;34:10258–10266.
   PubMed Web of Science ®Google Scholar
• Lin TS, Wu JH, Zhao XZ, et al. In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract. J Pharm Sci. 2014;103:927–936.
   PubMed Web of Science ®Google Scholar
• Shruti GS, Banerjee R. Intravesical drug delivery: challenges, current status, opportunities and novel strategies. J Control Release. 2010;148:147–159.
   PubMed Web of Science ®Google Scholar
• Jan B, Glen P, Juliane H, et al. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Int J Pharm. 2011;416:339–345.
   PubMed Web of Science ®Google Scholar
• Takashi N, Masafumi F, Megumi H, et al. Nanoparticulation of BCG-CWS for application to bladder cancer therapy. J Control Release. 2014;176:44–53.
   PubMed Web of Science ®Google Scholar
• Zheng YL, Yang WL, Wang CC, et al. Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. Eur J Pharm Biopharm. 2007;67:621–631.
   PubMed Web of Science ®Google Scholar
• Zhuo RX, Du B, Lu ZR. In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release. 1999;57:249–257.
   PubMed Web of Science ®Google Scholar
• Chen WC, Liaw CC, Chuang CK, et al. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2003;56:726–733.
   PubMed Web of Science ®Google Scholar
• Simeonova M, Velichkova R, Ivanova G, et al. Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil. Int J Pharm. 2003;263:133–140.
   PubMed Web of Science ®Google Scholar
• Çiftçi K, Hincal AA, Kaş HS, et al. Microspheres of 5-fluorouracil using poly(dl-lactic acid): in vitro release properties and distribution in mice after i.v. administration. Eur J Pharm Sci. 1994;1:249–258.
   Web of Science ®Google Scholar
• Neutsch L, Wambacher M, Wirth EM, et al. UPEC biomimickry at the urothelial barrier: lectin-functionalized PLGA microparticles for improved intravesical chemotherapy. Int J Pharm. 2013;450:163–176.
   PubMed Web of Science ®Google Scholar
• Rotman M, Aziz H, Porrazzo M, et al. Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. Int J Radiat Oncol Biol Phys. 1990;18:1131–1137.
   PubMed Web of Science ®Google Scholar
• Mahmoud MI, Salma AH, Tawfique, Mahmoud MM. Liposomal diltiazem HCl as ocular drug delivery system for glaucoma. Drug Dev Ind Pharm. 2014;40:765–773.
   PubMed Web of Science ®Google Scholar
• Haupt M, Thommes M, Heidenreich A, et al. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder. J Control Release. 2013;170:161–166.
   PubMed Web of Science ®Google Scholar
• Koennings S, Garcion E, Faisant N, et al. In vitro investigation of lipid implants as a controlled release system for interleukin-18. Int J Pharm. 2006;314:145–152.
   PubMed Web of Science ®Google Scholar
• Kreye F, Siepmann F, Zimmer A, et al. Controlled release implants based on cast lipid blends. Eur J Pharm Sci. 2011;43:78–83.
   PubMed Web of Science ®Google Scholar
• Sax G, Kessler B, Wolf E, et al. In-vivo biodegradation of extruded lipid implants in rabbits. J Control Release. 2012;163:195–202.
   PubMed Web of Science ®Google Scholar
• Even MP, Young K, Winter G, et al. In vivo investiga tion of twin-screw extruded lipid implants for vaccine delivery. Eur J Pharm Biopharm 2014;87:338–346.
   PubMed Web of Science ®Google Scholar
• Kreye F, Siepmann F, Siepmann J. Drug release mechanisms of compressed lipid implants. Int J Pharm. 2011;404:27–35.
   PubMed Web of Science ®Google Scholar
• Kreye F, Siepmann F, Willart JF, et al. Drug release mechanisms of cast lipid implants. Eur J Pharm Biopharm. 2011;78:394–400.
   PubMed Web of Science ®Google Scholar
• Sax G, Winter G. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants. J Control Release. 2012;163:187–194.
   PubMed Web of Science ®Google Scholar
• Kokkona M, Kallinteri P, Fatouros D, et al. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur J Pharm Sci. 2000;9:245–252.
   PubMed Web of Science ®Google Scholar
• Whitaker JF. A rapid and specific method for the determination of pancreatic lipase in serum and urine. Clin Chim Acta. 1973;44:133–138.
   PubMed Web of Science ®Google Scholar
• Chapus C, Rovery M, Sarda L, et al. Minireview on pancreatic lipase and colipase. Biochimie. 1988;70:1223–1233.
   PubMed Web of Science ®Google Scholar
• Junge W, Leybold K. Detection of colipase in serum and urine of pancreatitis patients. Clin Chim Acta. 1982;123:293–302.
   PubMed Web of Science ®Google Scholar
• Lawson AM, Madigan MJ, Shortland D, et al. Rapid diagnosis of Zellweger syndrome and infantile Refsum’s disease by fast atom bombardment-mass spectrometry of urine bile salts. Clin Chim Acta. 1986;161:221–231.
   PubMed Web of Science ®Google Scholar
• Comte B, Franceschi C, Sadoulet MO, et al. Detection of bile salt-dependent lipase, a 110 kDa pancreatic protein, in urines of healthy subjects. Kidney Int. 2006;69:1048–1055.
   PubMed Web of Science ®Google Scholar
• Abubakr O, Nur Jun S. Zhang Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm. 2010;26:965–969.
   Google Scholar
• Tomotaka S, Hidalgo IJ, Furubayashi T, et al. The transnasal delivery of 5-fluorouracil to the rat brain is enhanced by acetazolamide (the inhibitor of the secretion of cerebrospinal fluid). Int J Pharm. 2009;377:85–91.
   PubMed Web of Science ®Google Scholar
• Heo MY, Piao ZZ, Kim TW, et al. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch Pharm Res. 2005;28:604–611.
   PubMed Web of Science ®Google Scholar
• Thaned P, Natalie JM, Ian GT. Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int J Pharm. 2004;271:53–62.
   PubMed Web of Science ®Google Scholar
• Vogelhuber W, Magni E, Gazzaniga A, et al. Monolithic glyceryl trimyristate matrices for parenteral drug release applications. Eur J Pharm Biopharm. 2003;55:133–138.
   PubMed Web of Science ®Google Scholar
• Guse C, Koennings S, Kreye F, et al. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. Int J Pharm. 2006;314:137–144.
   PubMed Web of Science ®Google Scholar
• Siden R, Flowers WE, Levy RJ. Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization. Biomaterials. 1992;13:764–770.
   PubMed Web of Science ®Google Scholar
• Gameline EC, Danquechin-Dorval EM, Dumesnil YF. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer. 1996;77:441–451.
   PubMed Web of Science ®Google Scholar
• Kulthe SS, Bahekar JK, Godhani CC, et al. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. Drug Dev Ind Pharm. 2013;39:138–145.
   PubMed Web of Science ®Google Scholar